IL6 and COVID-19: Recent investigations in COVID-19 patients have reported elevated levels of inflammatory mediators such as IL-6, which suggests a contribution of this and other cytokines as well as their innate cell sources to the systemic cytokine response that is characteristic of the COVID-19 acute respiratory distress syndrome (ARDS) (65, 66).